Comparative Hepatic Outcomes of SGLT2i or DPP4i Compared to GLP‐1RA in CHB and T2DM Patients
Overall LRE risk was comparable between SGLT2i or DPP4i vs. GLP-1RA users. Further prospective studies are required to identify who can benefit from specific medication.
Authors
- Jin‐Ha Yoon (ORCID: https://orcid.org/0000-0003-4198-2955)
- Byungyoon Yun (ORCID: https://orcid.org/0000-0001-7055-6424)
- Beom Kyung Kim (ORCID: https://orcid.org/0000-0002-5363-2496)
- Jian Lee (ORCID: https://orcid.org/0009-0003-9089-895X)
- Heejoo Park
- Juyeon Oh (ORCID: https://orcid.org/0000-0002-9843-4928)
Institutions
- Yonsei University (KR)
- Severance Hospital (KR)
- Yonsei University Health System (KR)
Publication Details
- Journal
- Liver International
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1111/liv.70060
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.88
Funders
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea